Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Mahnkopf

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Therapeutics and Clinical Risk Management|April 8, 2014
"Denervation" of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcomeWolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Filiz Oezkan, et al.
JAMA|February 6, 2014
Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF studyNassir F Marrouche, David Wilber, Gerhard Hindricks, et al.
Journal of Cardiovascular Electrophysiology|February 18, 2021
Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study designNassir F Marrouche, Tom Greene, J Michael Dean, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2015
MRI Assessment of Ablation-Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF StudyNazem Akoum, David Wilber, Gerhard Hindricks, et al.
JAMA|June 21, 2022
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical TrialNassir F Marrouche, Oussama Wazni, Christopher McGann, et al.
Heart Rhythm|January 15, 2025
Application of artificial intelligence to analyze data from randomized controlled trials: An example from DECAAF IIMario Mekhael, Han Feng, Nazem Akoum, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 12, 2024
Direct-to-catheter ablation versus second line catheter ablation for persistent atrial fibrillation: Effect on arrhythmia recurrence, AF burden, early left atrium remodeling and quality of lifeHadi Younes, Besim Ademi, Eli Tsakiris, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 7, 2024
Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trialHadi Younes, Christian Sohns, Nazem Akoum, et al.
Heart Rhythm|September 8, 2024
Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trialNazem Akoum, Mario Mekhael, Felipe Bisbal, et al.
Frontiers in Medicine|February 8, 2021
Effects of Environmental Factors on Severity and Mortality of COVID-19Domagoj Kifer, Dario Bugada, Judit Villar-Garcia, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Therapeutics and Clinical Risk Management|April 8, 2014
"Denervation" of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcomeWolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Filiz Oezkan, et al.
JAMA|February 6, 2014
Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF studyNassir F Marrouche, David Wilber, Gerhard Hindricks, et al.
Journal of Cardiovascular Electrophysiology|February 18, 2021
Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study designNassir F Marrouche, Tom Greene, J Michael Dean, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2015
MRI Assessment of Ablation-Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF StudyNazem Akoum, David Wilber, Gerhard Hindricks, et al.
JAMA|June 21, 2022
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical TrialNassir F Marrouche, Oussama Wazni, Christopher McGann, et al.
Heart Rhythm|January 15, 2025
Application of artificial intelligence to analyze data from randomized controlled trials: An example from DECAAF IIMario Mekhael, Han Feng, Nazem Akoum, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 12, 2024
Direct-to-catheter ablation versus second line catheter ablation for persistent atrial fibrillation: Effect on arrhythmia recurrence, AF burden, early left atrium remodeling and quality of lifeHadi Younes, Besim Ademi, Eli Tsakiris, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|June 7, 2024
Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trialHadi Younes, Christian Sohns, Nazem Akoum, et al.
Heart Rhythm|September 8, 2024
Lesion delivery and scar formation in catheter ablation for atrial fibrillation: The DECAAF II trialNazem Akoum, Mario Mekhael, Felipe Bisbal, et al.
Frontiers in Medicine|February 8, 2021
Effects of Environmental Factors on Severity and Mortality of COVID-19Domagoj Kifer, Dario Bugada, Judit Villar-Garcia, et al.
Pageof 4